| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |